My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Kiniksa Pharmaceuticals, Ltd. - Class A Ordinary Shares (NQ:KNSA)

36.35 +0.27 (+0.75%)
Streaming Delayed Price Updated: 3:58 PM EDT, Sep 23, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 220,622
Open 35.89
Bid (Size) 36.33 (22)
Ask (Size) 36.35 (10)
Prev. Close 36.08
Today's Range 35.88 - 36.41
52wk Range 17.82 - 37.34
Shares Outstanding 71,726,685
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Kiniksa Pharmaceuticals International (NASDAQ:KNSA) Emerges as an Affordable Growth Opportunity
Kiniksa Pharmaceuticals (KNSA) offers strong growth potential at a reasonable valuation. With 125% EPS growth, no debt, and a forward P/E of 21.47, it's a compelling affordable growth stock. 
Via Chartmill
Kiniksa Pharmaceuticals (NASDAQ:KNSA) Emerges as a Top Affordable Growth Candidate
Kiniksa Pharma (KNSA) is a strong affordable growth stock with impressive revenue & EPS growth, a reasonable valuation, and a solid debt-free balance sheet. 
Via Chartmill

Performance

YTD
+82.3%
+82.3%
1 Month
+10.0%
+10.0%
3 Month
+26.6%
+26.6%
6 Month
+55.3%
+55.3%
1 Year
+47.6%
+47.6%

More News

Read More
Kiniksa Pharmaceuticals (NASDAQ:KNSA) Exhibits High Growth Momentum and Technical Breakout Potential
Via Chartmill
KINIKSA PHARMACEUTICALS INTE (NASDAQ:KNSA): A Strong Growth Stock with a Positive Technical Breakout
Via Chartmill
Kiniksa Pharmaceuticals International (NASDAQ:KNSA) – An Affordable Growth Stock with Strong Fundamentals and Fair Valuation
Via Chartmill
Earnings Scheduled For July 29, 2025
Via Benzinga
Earnings Preview: Kiniksa Pharmaceuticals
Via Benzinga
Earnings Scheduled For April 29, 2025
Via Benzinga
Earnings Scheduled For February 25, 2025
Via Benzinga
Kiniksa Pharmaceuticals (NASDAQ:KNSA) Aligns with Minervini’s Trend Model as a Strong Momentum Pick
Via Chartmill
Why CommScope Shares Are Trading Higher By Around 40%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Gilead Sciences Reports Earnings Thursday. Can The Highly Ranked Drugmaker Beat Its 237% Profit Surge Last Quarter?
Via Investor's Business Daily
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
Exploring Kiniksa Pharmaceuticals's Earnings Expectations
Via Benzinga
Kiniksa Pharmaceuticals: A 7.9 Score and Room for Growth
Via The Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Pony AI, Hims & Hers And Frontdoor Are Among Top 11 Mid-Cap Gainers Last Week (Apr 28-May 2): Are The Others In Your Portfolio?
Via Benzinga
Topics Artificial Intelligence
Kiniksa Pharmaceuticals Announces GRAMMY® Award-Winning Country Star, Carly Pearce, Joins the Life DisRPted™ Campaign, Adding to Voices Advocating for Awareness of Recurrent Pericarditis
From Kiniksa Pharmaceuticals, Ltd.
Via GlobeNewswire
These stocks are gapping in today's session
Via Chartmill
Honeywell Posts Better-Than-Expected Q1 Earnings, Joins Crown Holdings, Noble, Crane And Other Big Stocks Moving Higher On Tuesday
Via Benzinga
Examining the Future: Kiniksa Pharmaceuticals's Earnings Outlook
Via Benzinga
3 No-Brainer Healthcare Stocks to Buy With $1,000 Right Now
Via The Motley Fool
Kiniksa Pharmaceuticals Stock Is Attractive From Valuation Perspective-JP Morgan Analyst
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
NHL Hall-of-Famer, Henrik Lundqvist, Teams Up with Kiniksa Pharmaceuticals to Launch Life DisRPted™ Campaign to Drive Awareness of Recurrent Pericarditis
From Kiniksa Pharmaceuticals, Ltd.
Via GlobeNewswire

Frequently Asked Questions

Is Kiniksa Pharmaceuticals, Ltd. - Class A Ordinary Shares publicly traded?
Yes, Kiniksa Pharmaceuticals, Ltd. - Class A Ordinary Shares is publicly traded.
What exchange does Kiniksa Pharmaceuticals, Ltd. - Class A Ordinary Shares trade on?
Kiniksa Pharmaceuticals, Ltd. - Class A Ordinary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Kiniksa Pharmaceuticals, Ltd. - Class A Ordinary Shares?
The ticker symbol for Kiniksa Pharmaceuticals, Ltd. - Class A Ordinary Shares is KNSA on the Nasdaq Stock Market
What is the current price of Kiniksa Pharmaceuticals, Ltd. - Class A Ordinary Shares?
The current price of Kiniksa Pharmaceuticals, Ltd. - Class A Ordinary Shares is 36.35
When was Kiniksa Pharmaceuticals, Ltd. - Class A Ordinary Shares last traded?
The last trade of Kiniksa Pharmaceuticals, Ltd. - Class A Ordinary Shares was at 09/23/25 03:58 PM ET
What is the market capitalization of Kiniksa Pharmaceuticals, Ltd. - Class A Ordinary Shares?
The market capitalization of Kiniksa Pharmaceuticals, Ltd. - Class A Ordinary Shares is 2.61B
How many shares of Kiniksa Pharmaceuticals, Ltd. - Class A Ordinary Shares are outstanding?
Kiniksa Pharmaceuticals, Ltd. - Class A Ordinary Shares has 3B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.